20 European entrepreneurs within life sciences will compete for the attention and funds of possible investors, when the European Venture Contest (EVC) semifinal takes place on 24 October in the city of Aarhus, Denmark.
The participating entrepreneurs, coming from Denmark as well as a range of other European countries, will get the chance to present their business ideas to a panel of expert reviewers consisting of international venture capitalists, corporations, investors, international business executives and prestigious experts in their field.
“For the participating companies, the European Venture Contest is a great opportunity to present their business plan, to profile themselves internationally, and to make contact with future business partners”, says Tine Hartmann Nielsen, Life Sciences team leader from Invest in Denmark.
Networking is key to bring new life science products to the market
Peter Samuelsen from Acarix, one of this year’s participants working in the field of diagnostic methods for coronary artery, explains why he signed up for the contest:
“It is a complex and resource-demanding process to develop a new medtech product, and many good ideas never make it to the market. The EVC in Aarhus is an ideal opportunity for us to broaden our network among VC funds, which can help us attract more venture capital and develop our business.”
The 5 most promising concepts in Aarhus will be one step nearer the final in Berlin in December, where 120 companies operating within life sciences, ICT and cleantech will compete. But more than just winning the contest, it is an opportunity for the companies to network with potential business partners, and with 120 investors joining in Berlin.
“As a company you get very valuable connections. Initially, I was actually very sceptical and only joined the event because my colleague pushed me, but I am very pleased that we did. I was surprised how many major investors and interesting companies were actually present”, explains founder and CEO Prof. Dr. Edith Huland of the German company Immunservice, a biopharmaceutical company developing treatments for cancer and infectious diseases. Immunservice participated in EVC in Aarhus two years ago and ended up winning the Life Sciences final.
Denmark has a strong life science cluster
Denmark is an excellent setting for the competition. Its life sciences industry has developed into one of the strongest clusters in Europe, and it is an international example of how to successfully turn academic knowledge into commercial business. The industry consists of a dense network of universities, hospitals and companies working closely together within pharmaceuticals, biotechnology and medical technology.
“There is a high amount of skilled and competent people within the field of life sciences in Denmark, and a large pool of start-ups within biotechnology and medical technology companies, which offers great business and investment opportunities for international companies and VCs”, says Tine Hartmann Nielsen from Invest in Denmark.
The competition will take place on 24 October between 8.30am – 3.30pm at KPMG Aarhus, Værkmestervej 25, 8100 Aarhus C.
The media is welcome.
For further information please contact Life Science Team leader, Tine Hartmann Nielsen from Invest in Denmark at email@example.com or +45 2528 3744.